Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/040,921external-prioritypatent/US4356164A/en
Application filed by US Department of CommercefiledCriticalUS Department of Commerce
Priority to CA000413076ApriorityCriticalpatent/CA1155764A/fr
Application grantedgrantedCritical
Publication of CA1155764ApublicationCriticalpatent/CA1155764A/fr
Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen
Antibody to Australia antigen: detection with a simple radioimmune assay, incidence in military populations, and role in the prevention of hepatitis B with gamma globulin
Separation of various B-cell subpopulations from mouse spleen: I. Depletion of B cells by rosetting with glutaraldehyde-fixed, anti-immunoglobulin-coupled red blood cells
An enzyme‐linked immunosorbent assay for an antigen related to non‐a, non‐b hepatitis and its antibody: Partial characterization of the antigen and chimpanzee transmission